T/ZGCIT 015-2024 Active Group standards

T/ZGCIT 015-2024 Human umbilical cord mesenchymal stem cell clinical application guidelines for knee osteoarthritis

T/ZGCIT 015-2024 Human umbilical cord mesenchymal stem cell clinical application guidelines for knee osteoarthritis

Publish Date: 2024-12-30 Implement Date: 2024-12-30 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/ZGCIT 015-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical equipment
Publish Date: 2024-12-30
Implement Date: 2024-12-30

Scope

Scope: This document specifies the requirements for institutions and personnel involved in the treatment of knee osteoarthritis with human umbilical cord mesenchymal stem cells, the process of obtaining human umbilical cord mesenchymal stem cells and local injection treatment, as well as the post-treatment examination, follow-up tracking, and monitoring procedures for patients. This document is applicable to orthopedics and arthroscopic surgery departments in general hospitals for the treatment of knee osteoarthritis caused by degenerative lesions using human umbilical cord mesenchymal stem cells. Main technical content: This document specifies the requirements for institutions and personnel involved in the treatment of knee osteoarthritis with human umbilical cord mesenchymal stem cells, the process of obtaining human umbilical cord mesenchymal stem cells and local injection treatment, as well as the post-treatment examination, follow-up tracking, and monitoring procedures for patients.

Development Information

Related Standards

Contact Us